REGENXBIO INC (RGNX)
Sector: Health Care
Board of Directors
Director information for REGENXBIO INC
Board as disclosed in the proxy statement filed April 14, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alexandra Glucksmann, Ph.D. | Director; Member of Compensation Committee | 67 | [] | ["Compensation Committee"] | 2026 |
| Allan M. Fox | Director; Member of Nominating and Corporate Governance Committee | 78 | [] | ["Nominating and Corporate Governance Committee"] | 2026 |
| A.N. “Jerry” Karabelas, Ph.D. | Member of Compensation Committee | [] | ["Compensation Committee"] | 2026 | |
| Curran Simpson | Director, President and Chief Executive Officer | 64 | [] | [] | 2026 |
| Daniel Tassé | Chair of Compensation Committee | [] | ["Compensation Committee"] | 2026 | |
| David C. Stump, M.D. | Director | 76 | [] | ["Audit Committee","Nominating and Corporate Governance Committee"] | 2026 |
| George Migausky | Director; Chair of Audit Committee | 71 | [] | ["Audit Committee"] | 2026 |
| Jean Bennett, M.D., Ph.D. | Member of Nominating and Corporate Governance Committee | [] | ["Nominating and Corporate Governance Committee"] | 2026 | |
| Jennifer Zachary | Director; Member of Audit Committee | 48 | [] | ["Audit Committee"] | 2026 |
| Kenneth T. Mills | Chairman of the Board | 51 | [] | [] | 2026 |